150 related articles for article (PubMed ID: 37227042)
1. Non-restrictive open vial policy combined with the home visit vaccinations for improving BCG coverage in a high-incidence outreach region: A model-based cost-effectiveness analysis for Indonesia.
Machlaurin A; Luttjeboer J; Setiawan D; Sytse van der Werf T; Postma MJ
J Glob Health; 2023 May; 13():04049. PubMed ID: 37227042
[TBL] [Abstract][Full Text] [Related]
2. Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0-4 years.
Thysen SM; Fisker AB; Byberg S; Aaby P; Roy P; White R; Griffiths U; Harris RC
BMJ Glob Health; 2021 Aug; 6(8):. PubMed ID: 34344667
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study.
Machlaurin A; Dolk FCK; Setiawan D; van der Werf TS; Postma MJ
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33256143
[TBL] [Abstract][Full Text] [Related]
4. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of hepatitis A vaccination in Indonesia.
Suwantika AA; Beutels P; Postma MJ
Hum Vaccin Immunother; 2014; 10(8):2342-9. PubMed ID: 25424941
[TBL] [Abstract][Full Text] [Related]
7. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland.
Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M
Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.
Tseng CL; Oxlade O; Menzies D; Aspler A; Schwartzman K
BMC Public Health; 2011 Jan; 11():55. PubMed ID: 21269503
[TBL] [Abstract][Full Text] [Related]
9. Cost and cost-effectiveness of newborn home visits: findings from the Newhints cluster-randomised controlled trial in rural Ghana.
Pitt C; Tawiah T; Soremekun S; ten Asbroek AH; Manu A; Tawiah-Agyemang C; Hill Z; Owusu-Agyei S; Kirkwood BR; Hanson K
Lancet Glob Health; 2016 Jan; 4(1):e45-56. PubMed ID: 26639857
[TBL] [Abstract][Full Text] [Related]
10. The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model.
Clark M; Cameron DW
BMC Pediatr; 2006 Mar; 6():5. PubMed ID: 16515694
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
Faust L; Schreiber Y; Bocking N
BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
[TBL] [Abstract][Full Text] [Related]
12. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
Dye C
J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
[TBL] [Abstract][Full Text] [Related]
13. Paediatric tuberculosis during universal and selective
Kontturi A; Kekomäki S; Soini H; Ollgren J; Salo E
Euro Surveill; 2021 Mar; 26(11):. PubMed ID: 33739257
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of universal BCG vaccination of Japanese infants.
Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Dengue Vaccination in Indonesia: Considering Integrated Programs with
Suwantika AA; Kautsar AP; Supadmi W; Zakiyah N; Abdulah R; Ali M; Postma MJ
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32545688
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
17. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
[TBL] [Abstract][Full Text] [Related]
18. The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial.
Schaltz-Buchholzer F; Frankel HN; Benn CS
Glob Health Action; 2017; 10(1):1-4. PubMed ID: 28169606
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study.
Liao Q; Zheng Y; Wang Y; Ye L; Liu X; Jiao W; Liu Y; Zhu Y; Jia J; Sun L; Shen A; Wan C
Int J Infect Dis; 2022 Aug; 121():113-119. PubMed ID: 35429637
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
